Aqilion initiates collaboration with Immunscape
Aqilion searches for early innovative pharmaceutical projects that are based on solid research resting on a firm biological foundation and offering both clinical relevance and patient benefit. Immunscape has developed innovative molecules that could potentially become new drugs for the treatment of cancer and autoimmune diseases. The project is currently in an early phase of development. The purpose of the new collaboration is to jointly assess and develop the commercial potential of the project. Aqilion can invest resources in interesting projects to further evaluate their potential and